Eris Lifesciences Limited (NSE:ERIS)

Eris Lifesciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 14, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	201,206	192,990	114,719	77,801	93,615	82,147
Market Cap Growth	9.23%	68.23%	47.45%	-16.89%	13.96%	64.00%
Enterprise Value	228,470	221,970	121,268	80,085	92,600	80,183
Last Close Price	1477.10	1417.35	838.59	568.87	677.58	590.51
PE Ratio	48.50	54.85	29.26	20.36	23.05	23.13
Forward PE	32.50	38.80	25.79	17.15	21.23	21.38
PS Ratio	6.74	6.70	5.76	4.68	7.06	6.89
PB Ratio	5.74	5.90	3.56	3.50	4.91	5.21
P/TBV Ratio	-	-	-	-	8.10	10.28
P/FCF Ratio	33.29	21.21	32.15	-	36.39	23.50
P/OCF Ratio	24.57	18.12	23.60	26.67	24.75	21.89
PEG Ratio	1.00	1.29	1.61	1.91	1.46	1.14
EV/Sales Ratio	7.65	7.71	6.09	4.82	6.98	6.72
EV/EBITDA Ratio	21.42	22.09	18.30	15.23	19.18	18.82
EV/EBIT Ratio	29.64	31.59	24.53	18.99	21.81	20.69
EV/FCF Ratio	37.80	24.39	33.98	-	36.00	22.94
Debt / Equity Ratio	0.68	0.76	0.86	0.40	0.05	0.01
Debt / EBITDA Ratio	2.24	2.44	4.13	1.66	0.19	0.04
Debt / FCF Ratio	3.95	2.72	7.79	-	0.36	0.05
Asset Turnover	0.42	0.41	0.37	0.56	0.65	0.70
Inventory Turnover	2.27	2.80	2.47	2.90	2.49	2.95
Quick Ratio	0.47	0.56	0.75	1.22	1.99	1.78
Current Ratio	0.91	0.89	0.91	1.73	3.14	2.80
Return on Equity (ROE)	13.42%	11.54%	14.59%	18.12%	23.29%	24.72%
Return on Assets (ROA)	6.78%	6.24%	5.77%	8.87%	12.92%	14.31%
Return on Capital (ROIC)	8.15%	7.47%	6.78%	10.31%	14.76%	16.70%
Return on Capital Employed (ROCE)	13.70%	12.40%	11.00%	13.10%	20.50%	23.20%
Earnings Yield	2.06%	1.82%	3.42%	4.91%	4.34%	4.32%
FCF Yield	3.00%	4.71%	3.11%	-7.07%	2.75%	4.26%
Dividend Yield	0.49%	0.52%	-	1.29%	0.89%	0.93%
Payout Ratio	24.10%	28.44%	-	26.14%	20.10%	21.03%
Buyback Yield / Dilution	-0.01%	-0.09%	-0.03%	-0.19%	-0.02%	1.03%
Total Shareholder Return	0.48%	0.43%	-0.03%	1.10%	0.86%	1.97%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.